GL1X · GenesisL1 explorer

Research workbench

Lyn tyrosine kinase domain, apo form

Analyse Lyn tyrosine kinase domain, apo form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZV7
Type
protein
Length
257 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase lyn
EC
2.7.10.2
UniProt
P25911
Pockets
1 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase lyn (EC 2.7.10.2)protein25740% helix, 18% strandP25911

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14260.680.8048empty

Compared structures

  • 2ZV7 · Lyn Tyrosine Kinase Domain, apo form · the same entry in another collection · chain A against A, TM-score 1.00
  • P25911 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase lyn (P25911) · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.